Literature DB >> 29564550

UVA-photoprotective potential of silymarin and silybin.

Alena Rajnochová Svobodová1, Eva Gabrielová1, Loizos Michaelides1, Pavel Kosina1, Alena Ryšavá1, Jitka Ulrichová1, Bohumil Zálešák2, Jitka Vostálová3.   

Abstract

Exposure to solar radiation is a major cause of environmental human skin damage. The main constituent of solar UV light is UVA radiation (320-400 nm); however, the need for protection against UVA has been marginalized for a long time. As a result, there is still a lack of useful agents for UVA protection. In this study, the effect of silymarin (SM) and its main constituent silybin (SB) pre-treatment on UVA-stimulated damage to primary human dermal fibroblasts were carried out. The cells were pre-treated for 1 h with SB or SM and then were exposed to UVA light, using a solar simulator. The effect of SB and SM on reactive oxygen species (ROS) and glutathione (GSH) level, caspase-3 activity, single-strand breaks (SSB) formation and protein level of matrix metalloproteinase-1 (MMP-1), heme oxygenase-1 (HO-1), and heat shock protein (HSP70) was evaluated. Treatment with both SM and SB resulted in a reduction in UVA-stimulated ROS generation and SSB production, as well as in the prevention of GSH depletion, a decrease in the activation of caspase-3 and protein level of MMP-1. They also moderately increased HO-1 level and reduced HSP70 level. Our data showed that both SM and SB are non-phototoxic and have UVA-photoprotective potential and could be useful agents for UV-protective dermatological preparations.

Entities:  

Keywords:  Dermal fibroblasts; Flavonolignan; Heat shock protein; Metalloproteinase-1; Oxidative damage; SPF

Mesh:

Substances:

Year:  2018        PMID: 29564550     DOI: 10.1007/s00403-018-1828-6

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  8 in total

1.  Photoprotective properties of new derivatives of kinetin.

Authors:  Vostálová Jitka; Škařupová Denisa; Plíhalová Lucie; Martin Hönig; Zálešák Bohumil; Rajnochová Svobodová Alena
Journal:  Photochem Photobiol Sci       Date:  2022-10-20       Impact factor: 4.328

Review 2.  Genome-Protecting Compounds as Potential Geroprotectors.

Authors:  Ekaterina Proshkina; Mikhail Shaposhnikov; Alexey Moskalev
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

3.  Mechanisms of oral absorption improvement for insoluble drugs by the combination of phospholipid complex and SNEDDS.

Authors:  Yingpeng Tong; Qin Zhang; Wen Shi; Jianxin Wang
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

Review 4.  The Modulatory Influence of Plant-Derived Compounds on Human Keratinocyte Function.

Authors:  Anna Merecz-Sadowska; Przemysław Sitarek; Karolina Zajdel; Ewa Kucharska; Tomasz Kowalczyk; Radosław Zajdel
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

5.  Protective Effects and Molecular Mechanism of Total Flavonoids from Lycium Barbarum Leaves on Photoaged Human Dermal Fibroblasts.

Authors:  Fei Song; Lihua Wang; Jing Mu; Huisheng Ma
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-28       Impact factor: 2.650

Review 6.  Selected Flavonoids to Target Melanoma: A Perspective in Nanoengineering Delivery Systems.

Authors:  Tiago E Coutinho; Eliana B Souto; Amélia M Silva
Journal:  Bioengineering (Basel)       Date:  2022-06-29

Review 7.  Mechanistic Insights into the Pharmacological Significance of Silymarin.

Authors:  Karan Wadhwa; Rakesh Pahwa; Manish Kumar; Shobhit Kumar; Prabodh Chander Sharma; Govind Singh; Ravinder Verma; Vineet Mittal; Inderbir Singh; Deepak Kaushik; Philippe Jeandet
Journal:  Molecules       Date:  2022-08-21       Impact factor: 4.927

8.  Anticatabolic and Anti-Inflammatory Effects of Myricetin 3-O-β-d-Galactopyranoside in UVA-Irradiated Dermal Cells via Repression of MAPK/AP-1 and Activation of TGFβ/Smad.

Authors:  Jung Hwan Oh; Fatih Karadeniz; Jung Im Lee; So Young Park; Youngwan Seo; Chang-Suk Kong
Journal:  Molecules       Date:  2020-03-14       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.